Literature DB >> 30442298

HF Mortality Trends Under Medicare Readmissions Reduction Program at Penalized and Nonpenalized Hospitals.

Peter Huckfeldt, José Escarce, Andrew Wilcock, Neeraj Sood, Brendan Rabideau, Ioana Popescu, Teryl Nuckols.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30442298      PMCID: PMC6668997          DOI: 10.1016/j.jacc.2018.08.2174

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.

Authors:  Ankur Gupta; Larry A Allen; Deepak L Bhatt; Margueritte Cox; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Eric D Peterson; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow
Journal:  JAMA Cardiol       Date:  2018-01-01       Impact factor: 14.676

2.  Recent Trends in Heart Failure-related Mortality: United States, 2000-2014.

Authors:  Hanyu Ni; Jiaquan Xu
Journal:  NCHS Data Brief       Date:  2015-12

3.  Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.

Authors:  Nihar R Desai; Joseph S Ross; Ji Young Kwon; Jeph Herrin; Kumar Dharmarajan; Susannah M Bernheim; Harlan M Krumholz; Leora I Horwitz
Journal:  JAMA       Date:  2016-12-27       Impact factor: 56.272

4.  Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia.

Authors:  Harlan M Krumholz; Zhenqiu Lin; Patricia S Keenan; Jersey Chen; Joseph S Ross; Elizabeth E Drye; Susannah M Bernheim; Yun Wang; Elizabeth H Bradley; Lein F Han; Sharon-Lise T Normand
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

  4 in total
  7 in total

1.  Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.

Authors:  Enrico G Ferro; Eric A Secemsky; Rishi K Wadhera; Eunhee Choi; Jordan B Strom; Jason H Wasfy; Yun Wang; Changyu Shen; Robert W Yeh
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

2.  Association of the Medicare Value-Based Purchasing Program With Changes in Patient Care Experience at Safety-net vs Non-Safety-net Hospitals.

Authors:  Nicholas Chiu; Rahul Aggarwal; Yang Song; Rishi K Wadhera
Journal:  JAMA Health Forum       Date:  2022-07-08

3.  Evaluation of Hospital Performance Using the Excess Days in Acute Care Measure in the Hospital Readmissions Reduction Program.

Authors:  Rishi K Wadhera; Karen E Joynt Maddox; Nihar R Desai; Bruce E Landon; Muthiah Vaduganathan Md; Lauren G Gilstrap; Changyu Shen; Robert W Yeh
Journal:  Ann Intern Med       Date:  2020-10-13       Impact factor: 25.391

4.  Thirty-Day Postdischarge Mortality Among Black and White Patients 65 Years and Older in the Medicare Hospital Readmissions Reduction Program.

Authors:  Peter Huckfeldt; José Escarce; Neeraj Sood; Zhiyou Yang; Ioana Popescu; Teryl Nuckols
Journal:  JAMA Netw Open       Date:  2019-03-01

5.  Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.

Authors:  Rishi K Wadhera; Karen E Joynt Maddox; Dhruv S Kazi; Changyu Shen; Robert W Yeh
Journal:  BMJ       Date:  2019-08-12

6.  Did the Hospital Readmissions Reduction Program Reduce Readmissions without Hurting Patient Outcomes at High Dual-Proportion Hospitals Prior to Stratification?

Authors:  Zhiyou Yang; Peter Huckfeldt; Jose J Escarce; Neeraj Sood; Teryl Nuckols; Ioana Popescu
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

7.  Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States.

Authors:  Rohan Khera; Yongfei Wang; Susannah M Bernheim; Zhenqiu Lin; Harlan M Krumholz
Journal:  BMJ       Date:  2020-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.